These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
318 related articles for article (PubMed ID: 35396345)
1. Of the many cellular responses activated by TP53, which ones are critical for tumour suppression? Thomas AF; Kelly GL; Strasser A Cell Death Differ; 2022 May; 29(5):961-971. PubMed ID: 35396345 [TBL] [Abstract][Full Text] [Related]
2. p53 efficiently suppresses tumor development in the complete absence of its cell-cycle inhibitory and proapoptotic effectors p21, Puma, and Noxa. Valente LJ; Gray DH; Michalak EM; Pinon-Hofbauer J; Egle A; Scott CL; Janic A; Strasser A Cell Rep; 2013 May; 3(5):1339-45. PubMed ID: 23665218 [TBL] [Abstract][Full Text] [Related]
3. How does p53 induce apoptosis and how does this relate to p53-mediated tumour suppression? Aubrey BJ; Kelly GL; Janic A; Herold MJ; Strasser A Cell Death Differ; 2018 Jan; 25(1):104-113. PubMed ID: 29149101 [TBL] [Abstract][Full Text] [Related]
4. Combined loss of PUMA and p21 accelerates c-MYC-driven lymphoma development considerably less than loss of one allele of p53. Valente LJ; Grabow S; Vandenberg CJ; Strasser A; Janic A Oncogene; 2016 Jul; 35(29):3866-71. PubMed ID: 26640149 [TBL] [Abstract][Full Text] [Related]
5. Combined absence of TRP53 target genes ZMAT3, PUMA and p21 cause a high incidence of cancer in mice. Brennan MS; Brinkmann K; Romero Sola G; Healey G; Gibson L; Gangoda L; Potts MA; Lieschke E; Wilcox S; Strasser A; Herold MJ; Janic A Cell Death Differ; 2024 Feb; 31(2):159-169. PubMed ID: 38110554 [TBL] [Abstract][Full Text] [Related]
6. Puma, noxa, p53, and p63 differentially mediate stress pathway induced apoptosis. Wang J; Thomas HR; Li Z; Yeo NCF; Scott HE; Dang N; Hossain MI; Andrabi SA; Parant JM Cell Death Dis; 2021 Jun; 12(7):659. PubMed ID: 34193827 [TBL] [Abstract][Full Text] [Related]
7. A novel ATM/TP53/p21-mediated checkpoint only activated by chronic γ-irradiation. Cao L; Kawai H; Sasatani M; Iizuka D; Masuda Y; Inaba T; Suzuki K; Ootsuyama A; Umata T; Kamiya K; Suzuki F PLoS One; 2014; 9(8):e104279. PubMed ID: 25093836 [TBL] [Abstract][Full Text] [Related]
8. Absence of p53-dependent apoptosis leads to UV radiation hypersensitivity, enhanced immunosuppression and cellular senescence. Tavana O; Benjamin CL; Puebla-Osorio N; Sang M; Ullrich SE; Ananthaswamy HN; Zhu C Cell Cycle; 2010 Aug; 9(16):3328-36. PubMed ID: 20703098 [TBL] [Abstract][Full Text] [Related]
9. Roles of TP53 in determining therapeutic sensitivity, growth, cellular senescence, invasion and metastasis. McCubrey JA; Lertpiriyapong K; Fitzgerald TL; Martelli AM; Cocco L; Rakus D; Gizak A; Libra M; Cervello M; Montalto G; Yang LV; Abrams SL; Steelman LS Adv Biol Regul; 2017 Jan; 63():32-48. PubMed ID: 27776972 [TBL] [Abstract][Full Text] [Related]
10. In several cell types tumour suppressor p53 induces apoptosis largely via Puma but Noxa can contribute. Michalak EM; Villunger A; Adams JM; Strasser A Cell Death Differ; 2008 Jun; 15(6):1019-29. PubMed ID: 18259198 [TBL] [Abstract][Full Text] [Related]
11. Should mutant TP53 be targeted for cancer therapy? Wang Z; Strasser A; Kelly GL Cell Death Differ; 2022 May; 29(5):911-920. PubMed ID: 35332311 [TBL] [Abstract][Full Text] [Related]
12. p53 and Tumor Suppression: It Takes a Network. Boutelle AM; Attardi LD Trends Cell Biol; 2021 Apr; 31(4):298-310. PubMed ID: 33518400 [TBL] [Abstract][Full Text] [Related]
13. Elucidating the chain of command: our current understanding of critical target genes for p53-mediated tumor suppression. Indeglia A; Murphy ME Crit Rev Biochem Mol Biol; 2024; 59(1-2):128-138. PubMed ID: 38661126 [No Abstract] [Full Text] [Related]
14. Mouse models to investigate in situ cell fate decisions induced by p53. Lieschke E; Thomas AF; Kueh A; Atkin-Smith GK; Baldoni PL; La Marca JE; Young S; Huang AS; Ross AM; Whelan L; Kaloni D; Tai L; Smyth GK; Herold MJ; Hawkins ED; Strasser A; Kelly GL EMBO J; 2024 Oct; 43(19):4406-4436. PubMed ID: 39160273 [TBL] [Abstract][Full Text] [Related]
15. The role of DNA damage responses in p53 biology. Speidel D Arch Toxicol; 2015 Apr; 89(4):501-17. PubMed ID: 25618545 [TBL] [Abstract][Full Text] [Related]
17. Therapeutic Response to Non-genotoxic Activation of p53 by Nutlin3a Is Driven by PUMA-Mediated Apoptosis in Lymphoma Cells. Valente LJ; Aubrey BJ; Herold MJ; Kelly GL; Happo L; Scott CL; Newbold A; Johnstone RW; Huang DC; Vassilev LT; Strasser A Cell Rep; 2016 Mar; 14(8):1858-66. PubMed ID: 26904937 [TBL] [Abstract][Full Text] [Related]
18. Noxa induces apoptosis in oncogene-expressing cells through catch-and-release mechanism operating between Puma and Mcl-1. Nakajima W; Tanaka N Biochem Biophys Res Commun; 2011 Oct; 413(4):643-8. PubMed ID: 21945433 [TBL] [Abstract][Full Text] [Related]
19. Effects of TP53 mutational status on gene expression patterns across 10 human cancer types. Parikh N; Hilsenbeck S; Creighton CJ; Dayaram T; Shuck R; Shinbrot E; Xi L; Gibbs RA; Wheeler DA; Donehower LA J Pathol; 2014 Apr; 232(5):522-33. PubMed ID: 24374933 [TBL] [Abstract][Full Text] [Related]
20. A role for c-myc in DNA damage-induced apoptosis in a human TP53-mutant small-cell lung cancer cell line. Supino R; Perego P; Gatti L; Caserini C; Leonetti C; Colantuono M; Zuco V; Carenini N; Zupi G; Zunino F Eur J Cancer; 2001 Nov; 37(17):2247-56. PubMed ID: 11677115 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]